EA202191657A1 - EXPRESSION MODULATORS HSD17B13 - Google Patents
EXPRESSION MODULATORS HSD17B13Info
- Publication number
- EA202191657A1 EA202191657A1 EA202191657A EA202191657A EA202191657A1 EA 202191657 A1 EA202191657 A1 EA 202191657A1 EA 202191657 A EA202191657 A EA 202191657A EA 202191657 A EA202191657 A EA 202191657A EA 202191657 A1 EA202191657 A1 EA 202191657A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- hsd17b13
- expression modulators
- expression
- compounds
- methods
- Prior art date
Links
- 102100037429 17-beta-hydroxysteroid dehydrogenase 13 Human genes 0.000 title abstract 3
- 101000806241 Homo sapiens 17-beta-hydroxysteroid dehydrogenase 13 Proteins 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Предусматриваются способы, соединения и композиции, применимые для подавления экспрессии HSD17B13. Такие соединения, композиции и способы являются применимыми для лечения, предупреждения или уменьшения интенсивности проявлений заболевания, ассоциированного c HSD17B13.Methods, compounds, and compositions useful for suppressing HSD17B13 expression are provided. Such compounds, compositions and methods are useful for treating, preventing, or ameliorating disease associated with HSD17B13.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962827524P | 2019-04-01 | 2019-04-01 | |
| PCT/US2019/068051 WO2020132564A1 (en) | 2018-12-21 | 2019-12-20 | Modulators of hsd17b13 expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202191657A1 true EA202191657A1 (en) | 2021-11-08 |
Family
ID=78768120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202191657A EA202191657A1 (en) | 2019-04-01 | 2019-12-20 | EXPRESSION MODULATORS HSD17B13 |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA202191657A1 (en) |
-
2019
- 2019-12-20 EA EA202191657A patent/EA202191657A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018004620A2 (en) | kras expression modulators | |
| EA202092748A1 (en) | APOL1 EXPRESSION MODULATORS | |
| EA202191519A1 (en) | TREX1 MODULATORS | |
| EA202190708A1 (en) | EXPRESSION MODULATORS PNPLA3 | |
| ECSP21053104A (en) | HSD17B13 EXPRESSION MODULATORS | |
| EA201992170A1 (en) | PCSK9 EXPRESSION MODULATORS | |
| MX2020007369A (en) | Modulators of dnm2 expression. | |
| EA202191058A1 (en) | ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION | |
| PE20210109A1 (en) | IRF4 EXPRESSION MODULATORS | |
| MX2021010152A (en) | MODULATORS OF MALAT1 EXPRESSION. | |
| CL2021001246A1 (en) | Irf5 expression modulators. | |
| EA201992302A1 (en) | COMPOUNDS USED AS ALCAT1 INHIBITORS | |
| EA202190226A1 (en) | METHODS FOR TREATMENT OF HFpEF USING DAPAGLIFLOSIN AND COMPOSITIONS CONTAINING IT | |
| EA202190045A1 (en) | COMPOSITIONS / COMPOSITIONS CONTAINING IBRUTINIB | |
| UY38472A (en) | FOXP3 EXPRESSION MODULATORS | |
| MX2020003554A (en) | MODULATORS OF ENaC EXPRESSION. | |
| EA202191657A1 (en) | EXPRESSION MODULATORS HSD17B13 | |
| AR117079A1 (en) | FOXP3 EXPRESSION MODULATORS | |
| EA202092981A1 (en) | ANTIBODIES TO L1CAM AND THEIR APPLICATION | |
| EA202092733A1 (en) | PD-1 / PD-L1 INHIBITORS | |
| EA202091694A1 (en) | PD-1 / PD-L1 INHIBITORS | |
| EA202092947A1 (en) | ANTI-PVRIG / ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF THEIR APPLICATION | |
| EA201992045A1 (en) | INHIBITORS PD-1 / PD-L1 | |
| EA201890746A1 (en) | PCNA INHIBITORS |